Drug Database
Back to search

Sweden· SE-20240802000103

Dibaglep 100 mg/10 mg Filmdragerad tablett

A medicinal product containing sitagliptin + dapagliflozin, registered in Sweden by Viatris Limited.

Checked against Swedish Medical Products Agency (Sweden) on

Informational only — not a medical device.

SOURCE REGISTER · SESwedish Medical Products Agency (Sweden)normalisedDibaglep 100 mg/10 mg Filmdragerad ta…ATC—REGISTER NO.SE-20240802000103PACKS LISTED1CHECKEDOctober 1, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about sitagliptin + dapagliflozinAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

The record

At a glance

Swedish Medical Products Agency (Sweden)
Active substance
Sitagliptin + Dapagliflozin
Manufacturer
Viatris Limited
Country
Sweden (SE)
ATC code
—
Reimbursed
Not published by this register
Source register
Swedish Medical Products Agency (Sweden)
Last checked
October 1, 2026

Packs & prices · 1

  • se_varunummer
    20240802000103

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Sitagliptin + dapagliflozin in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All sitagliptin + dapagliflozin products

Authorised across Europe · EMA

The same active substance is authorised in 20 EEA countries. Names it is sold under:

  • Austria · Sitagliptin/Dapagliflozin Ratiopharm, Sitagliptin/Dapagliflozin Tad
  • Belgium · Dibaglep
  • Bulgaria · Даградуо, Далзиор S Комбо
  • Cyprus · Gludapsi, Sitagliptin/Dapagliflozin Tad
  • Czechia · Dagrafors Duo
  • Germany · Dagraduo, Dapasitazin
  • Estonia · Dagraduo, Sitagliptin/Dapagliflozin Teva
  • Finland · Dagraduo
  • Greece · Dagraduo, Dapsita
  • Croatia · Daglyfy, Dagraduo
  • Hungary · Dagrafors Duo
  • Lithuania · Axigalu
  • Luxembourg · Dibaglep
  • Latvia · Daplussi, Sitagliptin/Dapagliflozin Teva
  • Malta · Gludapsi
  • Poland · Dagraduo
  • Portugal · Dagraduo
  • Romania · Dagraduo, Dibaglep
  • Slovenia · Daplussi
  • Slovakia · Dagraduo

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/0bd9a784-6282-499e-8353-ed3da3e2f524
GET /v1/drugs/0bd9a784-6282-499e-8353-ed3da3e2f524?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "lakemedelsverket",
  "doc_types": [
    "sRMP",
    "PL",
    "SmPC"
  ],
  "se_npl_id": "20240802000103",
  "product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20240802000103",
  "product_doc_link": "https://docetp.mpa.se/LMF/Dibaglep%20100%20mg_10%20mg%20film-coated%20tablet%20ENG%20SmPC_09001bee84e09e20.pdf"
}
API referenceMCP serverPlans

See everything about sitagliptin + dapagliflozin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console